Alembic secures USFDA nod for generic Diltiazem
INDIA—Alembic Pharmaceuticals Ltd, a prominent Indian pharmaceutical company, has gained final...
Read MoreSelect Page
Nov 12, 2024
INDIA—Alembic Pharmaceuticals Ltd, a prominent Indian pharmaceutical company, has gained final...
Read MoreOct 11, 2024
INDIA—GlaxoSmithKline Pharmaceuticals (GSK), India’s second-largest pharmaceutical company,...
Read MoreOct 11, 2024
INDIA—Zydus Lifesciences Ltd has received final approval from the United States Food and Drug...
Read MoreAug 29, 2024
INDIA – The National Research Center for Banana (NRCB) in Tiruchirappalli has announced plans to...
Read MoreAug 28, 2024
INDIA— Cambrian Bioworks, a Bangalore-based biotechnology firm, has raised US$1.45 million in seed...
Read MoreJul 29, 2024
INDIA – Indian drugmaker Sun Pharma announced that the U.S. Food and Drug Administration (FDA) has...
Read MoreJul 19, 2024
INDIA—French drugmaker Sanofi has announced plans to invest €400 million (US$435 million) over the...
Read MoreJul 19, 2024
INDIA—Zydus Lifesciences Ltd has entered into a non-exclusive patent licensing agreement with...
Read MoreJul 11, 2024
INDIA — Healthcare VR developer MediSim VR has partnered with Kusum Dhirajlal (KD) Hospital to...
Read MoreJul 8, 2024
INDIA — AstraZeneca India Private Limited (AZIPL), the Global Capability Centre (GCC) of...
Read More